Pillasco, Concepcion F.
HRN: 13-19-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2024
CEFTRIAXONE 1G (VIAL)
09/30/2024
10/07/2024
IV
2g
Q24HRS
Multiple Soft Tissue Injury Secondary MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes